Talis Biomedical Corp
TLISDelisted Sep 20, 2024- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001584751
Talis Biomedical Corp was delisted on Sep 20, 2024; its insiders filed their last Form 4 on Sep 9, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $6.84M in total; Greenlight Capital was the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Talis Biomedical Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Talis Biomedical Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Leonard Braden Michael | 10% Owner | 248,702Indirect | Sep 9, 2024 | 0 |
| Lukowiak Andrew A | President | – | Aug 2, 2023 | 0 |
| Markovich Rebecca | Interim CFO | – | Jul 18, 2023 | 0 |
| Baker Julian | Director, 10% Owner | 7,053,176Indirect | Jun 13, 2023 | 0 |
| Baker Felix | Director, 10% Owner | 7,053,176Indirect | Jun 13, 2023 | 0 |
| Baker Bros. Advisors LP | Director, 10% Owner | 7,053,176Indirect | Jun 13, 2023 | 0 |
| Baker Brothers Life Sciences LP | Director, 10% Owner | 7,053,176Indirect | Jun 13, 2023 | 0 |
| 667, L.P. | Director, 10% Owner | 7,053,176Indirect | Jun 13, 2023 | 0 |
| Baker Bros. Advisors (GP) LLC | Director, 10% Owner | 7,053,176Indirect | Jun 13, 2023 | 0 |
| Popovits Kimberly J | Director | – | Jun 12, 2023 | 0 |
| Scott Randal W. | Director | – | Jun 12, 2023 | 0 |
| Dreismann Heinrich | Director | – | Jun 12, 2023 | 0 |
| Posard Matthew L. | Director | – | Jun 12, 2023 | 0 |
| Ismagilov Rustem F. | Director | – | Jun 12, 2023 | 0 |
| Gilliam Melissa | Director | – | Jun 12, 2023 | 0 |
| Moody John Roger Jr | Chief Financial Officer | – | Apr 11, 2023 | 0 |
| Kelley Robert J. | Chief Executive Officer | – | Apr 11, 2023 | 0 |
| Blaser Brian J | President and CEO | – | Dec 2, 2021 | 0 |
| Liu Douglas | Chief Operating Officer | – | Oct 5, 2021 | 0 |
| Ramakrishnan Ramesh | Other: Former Officer | 38,619 | Aug 17, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2021 (view filing) | Aug 13 | 4 days | Ramakrishnan RameshOther: Former Officer | SSale | −27.5K | $7.66 | −$210.7K | −41.6%38.6K after | |
| Nov 19, 2021 (view filing)4:09 PM ET | Nov 18 | 1 day | Baker Julian and 5 othersDirector, 10% Owner | PPurchase | +50.0K | $4.37 | +$218.3K | +0.7%7.05M after | |
| Aug 28, 2024 (view filing) | Aug 26-28 | 2 days | Leonard Braden Michael10% Owner | PPurchase | +14.4K | $3.91 | +$56.2K | +7.1%218.0K after | 2 lots |
| Sep 4, 2024 (view filing) | Aug 30 | 5 days | Leonard Braden Michael10% Owner | PPurchase | +151 | $4.25 | +$641.75 | +0.1%218.6K after | |
| Sep 5, 2024 (view filing) | Sep 3 | 2 days | Leonard Braden Michael10% Owner | PPurchase | +500 | $4.00 | +$2.00K | +0.2%218.6K after | |
| Sep 9, 2024 (view filing) | Sep 5-6 | 4 days | Leonard Braden Michael10% Owner | PPurchase | +30.1K | $1.47 | +$44.1K | +13.8%248.7K after | 2 lots |